Why is Fermenta Biotec. falling/rising?

As of 29-Jul, Fermenta Biotech Ltd's stock is currently priced at 369.50, reflecting a decrease of 7.5, or 1.99%. The stock has underperformed its sector today by 3.4%, and the delivery volume has significantly dropped by 61.08% compared to the 5-day average, indicating falling investor participation. Despite this recent decline, the stock has shown strong performance over the past month with a return of 14.20%, and it has generated a remarkable 50.20% return over the past year. The company has reported outstanding financial results, including a 279.46% growth in operating profit and a low debt-equity ratio of 0.32 times, which suggests a solid financial foundation. However, the stock's current price is lower than its 5-day moving average, which could be contributing to the recent downward movement.
In the broader market context, the stock's short-term performance has been notably weaker than the benchmark, with a 1-week return of -4.51% compared to the Sensex's -1.03%. While the stock has outperformed the BSE500 over the long term, the recent decline may be influenced by broader market conditions and reduced trading activity. Despite the company's strong fundamentals and attractive valuation, the current market sentiment appears to be affecting investor confidence, leading to the observed price drop.